Form 4 for EW Edwards Lifesciences
Accepted 2025-11-13 00:00:00 ET · period of report 2025-11-13 · accession 0001225208-25-009137 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-13 | 2025-11-13 | EW | Dahl Andrew M. | SVP, Corp. Ctrl | A - Grant | $0.00 | +1,160 | 9,183 | +14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-13 | A | A | 1,160 | $0.00 | 9,183.07 | D | — | — | (F1) These restricted stock units were granted on November 13, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. |